This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Cardiosonic Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Ronen Neeman: Innovator in Renal Denervation Technologies
Introduction
Ronen Neeman is a notable inventor based in Givataim, Israel. He has made significant contributions to the field of medical technology, particularly in the area of renal denervation. His innovative work focuses on devices and methods that enhance the effectiveness of renal sympathetic denervation treatments.
Latest Patents
Ronen Neeman holds a patent for "Devices and methods for renal denervation and assessment thereof." This invention relates to devices and methods for intravascular denervation and assessment, specifically targeting renal denervation. The patent describes an intravascular catheter designed for ultrasonic ablation of tissue, which includes a plurality of piezoelectric transceivers. Additionally, it introduces an intravascular distancing device that ensures a minimal distance between an ultrasound emitting element and the tissue, such as the blood vessel wall. The invention also addresses the assessment of renal sympathetic denervation treatment effectiveness by processing echo signals to characterize the physical and mechanical properties of blood vessels.
Career Highlights
Ronen Neeman is associated with Cardiosonic Ltd., a company that focuses on innovative medical technologies. His work at Cardiosonic has been instrumental in advancing the field of renal denervation, contributing to improved treatment options for patients with hypertension.
Collaborations
Ronen collaborates with talented individuals such as Ariel Sverdlik and Or Shabtay. Their combined expertise enhances the development of cutting-edge technologies in the medical field.
Conclusion
Ronen Neeman's contributions to renal denervation technologies exemplify the impact of innovation in medical science. His patent and work at Cardiosonic Ltd. highlight the importance of advancements in treatment methodologies for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile